Navigation Links
MedShape Solutions, Inc. Announces Breakthrough in ACL Reconstruction

ATLANTA, Feb. 8, 2011 /PRNewswire/ -- MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced the introduction and first human clinical use of ExoShape™ CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue graft fixation during anterior cruciate ligament (ACL) reconstructive surgery. After receiving 510(k) clearance from the U.S. Food and Drug Administration, the product was used successfully in a knee ligament reconstruction procedure performed by Champ L. Baker, Jr., M.D., at the Jack Hughston Memorial Hospital in Phenix City, Alabama. "I was impressed with the performance of the ExoShape device," commented Dr. Baker. "I believe that many surgeons will recognize the significant benefits of the ExoShape device and will adopt it for their soft tissue fixation procedures." MedShape intends to initiate a full market release of the product in June 2011.

ExoShape's design supports the evolution of reconstruction techniques to more accurately replicate complex native ACL functionality. This unique fixation device features a non-rotational deployment technique that preserves the surgeon's desired soft tissue graft bundle orientation and tension during single-tunnel double-bundle procedures, eliminating undesirable variables common to previous techniques.

When used with soft tissue grafts, traditional interference screws exhibit low fixation strength and can damage the graft during insertion. Many surgeons have turned to "sheath-and-screw" devices that offer improved graft fixation and graft protection. However, sheath-and-screw solutions can compromise graft bundle orientation due to sheath rotation within the tibial tunnel, the result of the significant manual torque required to drive the screw into the sheath and achieve adequate graft fixation. The need to drive screws in a direction counter to the desired direction of graft tension can also introduce undesirable laxity into the graft construct.

ExoShape addresses these issues with a series of design improvements:

  • The ExoShape device's unique deployment gun facilitates full expansion of the PEEK Altera shape memory sheath without rotational motion, thereby accurately preserving the surgeon's desired graft bundle orientation.

  • The ExoShape deployment gun and deployment cartridge combination utilizes a closed force loop for sheath expansion, eliminating the need for forward force on the sheath. This allows the surgeon to confirm desired graft tension prior to final device deployment. Graft tension remains unchanged during ExoShape deployment.

  • The use of MedShape's proprietary PEEK Altera polymer enables the sheath to be pre-compressed to a low profile for easy insertion, and then fully expanded for effective graft-to-tunnel compression and secure graft fixation.

  • The ExoShape deployment gun provides a convenient mechanical advantage for easy deployment of the ExoShape PEEK Altera shape memory sheath.

  • "ExoShape solves a significant problem common to a very large number of surgeries," said Rick Leach, vice president of Marketing at MedShape Solutions. "Over a quarter-million soft tissue ACL procedures were performed in 2010, and that number is expected to grow steadily. ExoShape will profoundly improve results for this increasingly common surgical procedure."

    For more information on ExoShape, or to view animation of ExoShape in action, please visit

    About MedShape Solutions, Inc.:MedShape Solutions, Inc. is a privately held medical device company focused on developing orthopedic devices from proprietary shape memory technology. In June 2010, the company's initial product, the MORPHIX™ Suture Anchor, received the prestigious Gold Award at the Medical Device + Design Excellence Awards (MDEA) meeting, based on its superior design and proprietary shape memory polymer. For more information about how MedShape is Shaping the Future of Orthopedics, visit

    ExoShape, PEEK Altera, MORPHIX, and Shaping the Future of Orthopedics are trademarks of MedShape Solutions, Inc.Media Contact:Jenn HarrisonCarabiner Communications

    SOURCE MedShape Solutions, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
    2. MedShape Solutions, Inc. Receives Industry Honors and Awards
    3. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
    4. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
    5. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
    6. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
    7. Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market
    8. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
    9. Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO
    10. Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company
    11. PatientSafe Solutions, Inc. Closes $30 Million Financing
    Post Your Comments:
    (Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
    (Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
    (Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
    Breaking Medicine Technology:
    (Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
    (Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
    (Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
    (Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
    (Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
    Breaking Medicine News(10 mins):